Background: Cardiovascular (CV) diseases are increasing in aging HIV-infected (HIV+) populations. Frequent CV risk behaviours are encountered in HIV+ cohorts, especially smoking. To compare differences in CV risk profile between HIV+ and comparable HIV-negative (HIV-) populations we analyzed data of two cohort studies from the Ruhr area in Germany. Methods: The HIV Heart cohort study (HH) is an ongoing prospective observational study to assess the frequency and clinical course of cardiac disorders in 1421 HIV+ outpatients. The Heinz Nixdorf study (HNR) is a population-based ongoing prospective cohort study with 4814 HIV-participants investigating CV risk factors in the general population. Both studies take place in the German Ruhr Area. HH study participants were retrospectively matched with HNR controls in a 1:2 ratio within the age range 45-75 years by continuous age and sex. Framingham Risk Score (FRS) was calculated for all participants without previously diagnosed CV diseases. To account for the matching design conditional logistic regression models were calculated to indentify associations between CV risk factors and HIV+ study participants. Results: After individual matching of 651 HH study participants (87.1% male) with 1192 HNR controls (86.7% male), there was no statistically significant difference in the FRS in men. FRS was significantly higher in HIV+ women than in HIV-controls (8.0±5.2 vs. 5.7±4.2). However there were differences in single variables of the FRS for both sexes. Systolic (137.1±25.0 vs. 127.3±20.8) and diastolic blood pressure (84.3±13.1 vs. 78.6±10.5) was only elevated in the HIV+ women compared to HIV-controls. Both LDL and HDL were significantly lower in HIV+ individuals. Diabetes mellitus tended to be lower in HIV+ men and increased in HIV+ women. The proportion of HIV+ current smokers was higher than in the HIV-controls (46% vs. 32%). Intake of lipid-lowering medication was significantly higher in HIV+ individuals (16% vs. 7%). No difference for anti-hypertensive medication was found. Background: Postoperative cardiac event is important cause of morbidity and mortality in patients undergoing a non-cardiac surgery. The role of preoperative echocardiography, biomarkers, and clinical risk factors such as Revised Cardiac Risk Index (RCRI) for the risk stratification has been known. However surgical parameters as predictors of development of postoperative cardiac event have not been well investigated yet. Methods: A total of 1,016 consecutive patients (66.6±12.5; 578 males) who performed cardiac consultation for elective non-cardiac surgery were studied. We evaluated the clinical risk factors including RCRI, echocardiographic and laboratory findings. Surgical data included types of surgery and anesthesia, surgical times, transfusion, and postoperative hemoglobin level. Major adverse cardiac event (MACE) was defined as a composite of all cause death, non-fatal myocardial infarction, and pulmonary edema within 30 days after surgery. Results: There were 95 (9.4%) postoperative MACEs. Age was significantly older and the RCRI was significantly higher in patients with postoperative MACE than those without. There were no significant differences in left ventricular ejection fraction and E/E' between the two groups. ST-T change on ECG was significantly higher in patients with postoperative MACE. Among the surgical parameters, surgical times (317±211 min versus 189±112 min, P<0.001), postoperative hemoglobin (10.7±1.9 g/dl versus 11.3±1.8 g/dl, P=0.007), the risk of surgery (P<0.001) and transfusion (37.6% versus 6.6%, P<0.001) were significantly different between the two groups. In the multivariate logistic regression analysis, surgical times (odds ratio [OR] 1.004, 95% CI 1.003-1.006, P<0.001) and transfusion during surgery (OR 4.578, 95% CI 2.599-8.065, P<0.001) were independent predictors for postoperative MACE in addition to age and ST-T change on ECG. Conclusion: Surgical parameters, themselves such as surgical times and transfusion, were strong predictors for development of postoperative MACE in patients undergoing non-cardiac surgery.
P5165 | BEDSIDE
The implication of surgical parameters as predictors of development of postoperative cardiac event in patients undergoing non-cardiac surgery Background: Postoperative cardiac event is important cause of morbidity and mortality in patients undergoing a non-cardiac surgery. The role of preoperative echocardiography, biomarkers, and clinical risk factors such as Revised Cardiac Risk Index (RCRI) for the risk stratification has been known. However surgical parameters as predictors of development of postoperative cardiac event have not been well investigated yet. Methods: A total of 1,016 consecutive patients (66.6±12.5; 578 males) who performed cardiac consultation for elective non-cardiac surgery were studied. We evaluated the clinical risk factors including RCRI, echocardiographic and laboratory findings. Surgical data included types of surgery and anesthesia, surgical times, transfusion, and postoperative hemoglobin level. Major adverse cardiac event (MACE) was defined as a composite of all cause death, non-fatal myocardial infarction, and pulmonary edema within 30 days after surgery. Results: There were 95 (9.4%) postoperative MACEs. Age was significantly older and the RCRI was significantly higher in patients with postoperative MACE than those without. There were no significant differences in left ventricular ejection fraction and E/E' between the two groups. ST-T change on ECG was significantly higher in patients with postoperative MACE. Among the surgical parameters, surgical times (317±211 min versus 189±112 min, P<0.001), postoperative hemoglobin (10.7±1.9 g/dl versus 11.3±1.8 g/dl, P=0.007), the risk of surgery (P<0.001) and transfusion (37.6% versus 6.6%, P<0.001) were significantly different between the two groups. In the multivariate logistic regression analysis, surgical times (odds ratio [OR] 1.004, 95% CI 1.003-1.006, P<0.001) and transfusion during surgery (OR 4.578, 95% CI 2.599-8.065, P<0.001) were independent predictors for postoperative MACE in addition to age and ST-T change on ECG. Conclusion: Surgical parameters, themselves such as surgical times and transfusion, were strong predictors for development of postoperative MACE in patients undergoing non-cardiac surgery. Purpose: The risk of venous thromboembolism (VTE) is increased during pregnancy and 6 weeks following childbirth. We examined risk factors for VTE following childbirth with focus on mode of birth, obesity, and age. Methods: Individual-level linkage of nationwide administrative registers was used. All women were included at the time of first birth during 2003-2011 and followed for six weeks. The risk of VTE (including deep venous thrombosis and pulmonary embolism) was investigated using a multivariable Cox regression including maternal age (at birth), pre-pregnancy body mass index (BMI), smoking (during pregnancy), previous VTE, and mode of delivery. Results: A total of 299,294 women were included of which 109 (0.04%) experienced a VTE. Multivariable Cox regression analysis revealed ( Figure 1 ) that maternal age above 35 years increased the risk with a hazard ratio (HR) 2.2 (95% confidence interval [CI] 1.4-3.6) compared to women 20-30 years old. Overweight (25≤BMI <30) and obesity (BMI≥30) increased the risk by HR 2.0 (CI 1.3-3.1) and 2.9 (CI 1.8-4.6), respectively, compared to normal weight women (18.5≤BMI <25). Previous VTE increased the risk substantially HR 51.2 (CI 29.4-89.3), whereas smoking was insignificant. Caesarean section was grouped in 4 depending on time of caesarean section (before onset of labour/during labour) and acute/elective. Only acute caesarean section before labour increased the risk of VTE significantly by HR 3.5 (CI 1.9-6.3) compared to vaginal delivery. 
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Conclusions:
In a large nationwide cohort of fertile women, acute caesarean section before labour, maternal age >35 years, and being overweight or obese were associated with an increased VTE risk following childbirth. Focus on risk stratification of pregnant women might help identify women at higher risk of VTE after birth.
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Derivation and validation of a risk chart for future ischaemic events and mortality following peripheral bypass surgery Purpose: Major cardiovascular events occur frequently in patients with peripheral arterial disease (PAD). A prediction model to identify determinants and quantify the risk of future ischaemic events could provide a personal risk profile to offer individualised patient care. In the present study, we developed and validated a risk chart in patients that underwent infrainguinal bypass surgery. Methods: The risk chart was derived from and validated in a clinical trial cohort including 2650 patients with severe PAD treated with infrainguinal bypass surgery between 1995-1998. Long-term follow-up data on the composite primary outcome event of all-cause death, non-fatal myocardial infarction, or non-fatal ischaemic stroke were collected from 1995 until 2009 in a subset of 482 patients, the development cohort. Data were obtained from hospital records, general practitioners, direct contact with patients or family. Determinants and the long-term risk of the primary outcome event were identified with multivariate Cox regression analyses. Validation of the risk chart was performed in the remaining 2168 of patients of the complete clinical trial cohort, the validation cohort. The 10-year follow-up data of the validation cohort were completed by consulting the National Death Registry and the National Registry of Hospital Discharge Diagnoses. Results: The follow-up data of the development cohort were complete in 454 of the 482 patients (94%) and in 2083 of the 2168 patients in the validation cohort (96%). The primary outcome event occurred in 321 (66.6%) patients in the development cohort during a median follow-up of 6.6 years and in 1371 (65.8%) patients in the validation cohort during a median follow-up of 6.6 years. Determi-nants included in the risk chart were age, critical limb ischaemia, diabetes, and a prior vascular intervention. The overall performance of the risk chart was fair with a Brier score of 0.19. ROC analysis showed good discriminatory performance of the risk chart with an area under the curve of 73%. The Hosmer-Lemeshow statistic (chi-squared 13.56; p=0.851) in combination with the calibration curve showed a good calibration of the risk chart. Conclusions: Our risk chart proves to be a valid tool for the prediction of mortality and major cardiovascular events in patients after peripheral bypass surgery and may serve as a tool for individualised care of patients with severe PAD. Purpose: The mechanisms underlying pathogenetic interactions between chronic obstructive pulmonary disease (COPD) and cardiovascular disease (CVD) are largely unknown despite a clinical mutual association in causing mortality and morbidity. Besides smoking, obesity and systemic inflammation share the complicity of being causative factors for both CVD and COPD. The present study aims to investigate, in an unselected, community-dwelling, elderly population, possible relationships between lung and cardiovascular impairements. Methods: A screening questionnaire was administered to 500 subjects aged from 65 to 84 years, randomly selected from the general population of Verona. All consenting participants underwent conventional pulmonary function test and diagnostic cardiovascular study (Echocardiografy, carotid Echo-Color-Doppler and Ankle-Brachial-Index). Blood pressure (BP), body mass index (BMI) and biochemical metabolic blood data were routinely obtained from all the participants. Results: COPD vs not-COPD patients differ for age (mean age: 70 vs 67 ys) but not for BP (mean: 130/80 vs 130/82 mmHg), BMI (mean: 28 vs 27 g/m 2 ), total cholesterol (mean: 192 vs 220 mg/dL) and glycaemia (mean: 102 vs 97 mg/dL). In COPD patient forced expiratory volume in the first second (FEV1) was linearly related to reductions in left ventricular end-diastolic volume (p<0.05) and stroke volume (p<0.05) but not with ejection fraction. Left ventricular mass is related to pO2 value (p<0.001). COPD patients related to control patients present: pathological Intima-Media-Thickness (mean: 0.12 vs 0.08 cm, p<0.001) and ABI (mean: 0.87 vs 1.05, p<0.001), a grater extension of atherosclerotic burden (mean number of carotid plague: 2.5 vs 1.2) and higher level of plaque calcification. Conclusions: Magnitude of changes in the cardiac structure and function is related to the severity of COPD. COPD patients show a great prevalence of peripheral vasculopathy and a typical pattern of cardiac and vascular remodelling that expose them to high cardiovascular risk. In particular the mechanical reduction of cardiac outflow linked to hyperinflation state, vascular tone regulation and stiffness due to O2 blood pressure variation and the great atherosclerotic tendency have to be taken into account in the evaluation of COPD patients. Purpose: There are few data assessing the relationship between circulating levels of C-reactive protein (CRP), fibrinogen, and interleukin-6 (IL-6) and the risk of vascular complications in individuals with type 2 diabetes mellitus (T2DM). We studied the associations between these inflammatory markers and the risk of major CV events (CV death, myocardial infarction or stroke), microvascular complications and death in patients T2DM who participated in the Action in Diabetes and Vascular Disease: Preterax and Diamicron Modified Release Controlled Evaluation (ADVANCE) trial. Methods: Baseline high sensitivity CRP, fibrinogen and IL-6 levels were determined in a case-cohort study (n=3,865), nested within the ADVANCE trial. Results: During 5 years of follow-up, 709 patients suffered a major CV event, 439 a microvascular complication and 706 died. All 3 markers were associated with an increased risk of CV events and death in analyses adjusting for age, sex Death stratified by prior CV disease and treatment groups. After further adjustment, for other potential confounders and for each other, only IL-6 was an independent predictor of these outcomes (hazard ratio [HR] for CV events 1.37 per 1 standard deviation [SD] increase in log IL-6, 95% confidence interval [CI] 1.24-1.51; HR for death 1.35, 95% CI 1.23-1.49). This increased hazard was seen in patients with and without prior CV disease (figure, HR per 1 SD increase in log IL-6). IL-6 significantly improved the prediction of CV events and death using reclassification statistics (net reclassification improvement in continuous models 23% for CV events and 30% for death). After adjustment, none of the markers predicted microvascular complications. Conclusions: IL-6, but not CRP or fibrinogen, levels add significantly to the prediction of CV events and mortality in individuals with T2DM.
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